Evidence map›Paper›PMID 18093525›Full record

ArticleNeuron2007

Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids.

Roger Cachope, Ken Mackie, Antoine Triller, John O'Brien, Alberto E Pereda

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 98 citations in OpenAlex.

  1. Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  2. Defining the electrical synapse.Nature reviews. Neuroscience · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Lights on Endocannabinoid-Mediated Synaptic Potentiation.Frontiers in molecular neuroscience · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Roger CachopeDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Ken Mackie
Antoine Triller
John O'Brien
Alberto E Pereda
Albert Einstein College of Medicine · USÉcole Normale Supérieure - PSL · FRThe University of Texas Health Science Center at Houston · USUniversity of Washington · US

Funding

REGULATION OF RETINAL GAP JUNCTIONSR01EY012857 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JOHN O'BRIEN · 2000 to 2026
$8.3M
Neuronal cannabinoidsR01DA011322 · NIDA · UNIVERSITY OF WASHINGTON · PI MACKIE, KENNETH · 1998 to 2014
$3.4M
Control of Junctional Conductance at Auditory AfferentsR01DC003186 · NIDCD · YESHIVA UNIVERSITY · PI PEREDA, ALBERTO E · 2002 to 2006
$1.7M
Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
In-vivo Modulation of Synapses by EndocannabinoidsR01NS052827 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PEREDA, ALBERTO E · 2006 to 2009
$1.1M
Control of Junctional Conductance at Auditory AfferentR56DC003186 · NIDCD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PEREDA, ALBERTO E · 2009 to 2009
$429k
CONTROL OF JUNCTIONAL CONDUCTANCE AT AUDITORY AFFERENTSR29DC003186 · NIDCD · YESHIVA UNIVERSITY · PI PEREDA, ALBERTO E · 1997 to 2001
$238k
NEI NIH HHS EY12857NEI NIH HHS R01 EY012857NIDA NIH HHS DA11322NIDA NIH HHS K05 DA021696NIDA NIH HHS R01 DA011322NIDCD NIH HHS DC03186NIDCD NIH HHS R01 DC003186NIDCD NIH HHS R29 DC003186NIDCD NIH HHS R56 DC003186NINDS NIH HHS NS0552827NINDS NIH HHS R01 NS052827
6 · The paper itself

Abstract

Endocannabinoids are well established as inhibitors of chemical synaptic transmission via presynaptic activation of the cannabinoid type 1 receptor (CB1R). Contrasting this notion, we show that dendritic release of endocannabinoids mediates potentiation of synaptic transmission at mixed (electrical and chemical) synaptic contacts on the goldfish Mauthner cell. Remarkably, the observed enhancement was not restricted to the glutamatergic component of the synaptic response but also included a parallel increase in electrical transmission. This effect involved the activation of CB1 receptors and was indirectly mediated via the release of dopamine from nearby varicosities, which in turn led to potentiation of the synaptic response via a cAMP-dependent protein kinase-mediated postsynaptic mechanism. Thus, endocannabinoid release can potentiate synaptic transmission, and its functional roles include the regulation of gap junction-mediated electrical synapses. Similar interactions between endocannabinoid and dopaminergic systems may be widespread and potentially relevant for the motor and rewarding effects of cannabis derivatives.

Indexed as

EndocannabinoidsAnalysis of VarianceAnimalsBenzoxazinesCannabinoid Receptor ModulatorsConnexinsCyclic AMP-Dependent Protein KinasesDopamineElectric StimulationEye ProteinsGap JunctionsGoldfishInhibitory Postsynaptic PotentialsMethoxyhydroxyphenylglycolMorpholinesNaphthalenes3,4-dihydroxyphenylglycol(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneAM 251BenzoxazinesCannabinoid Receptor Modulatorsconnexin 35 protein, vertebrateConnexinsCyclic AMP-Dependent Protein KinasesDopamineEndocannabinoidsEye Proteinsmetabotropic glutamate receptor type 1MethoxyhydroxyphenylglycolMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1Receptors, Metabotropic GlutamateRimonabantTyrosine 3-Monooxygenase

Identifiers

PMID18093525
PMCPMC2770950
OpenAlexW2001389812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.